Abstract
In radiation therapy, an ideal treatment plan always takes the treatment planner a couple of days to tweak repeatedly, owing to the complex dose distribution which requires the prescribed dose in the tumor area but significantly reduced radiation dose in the surrounding normal tissues. To facilitate this process, many deep learning-based studies have been devoted to the automatical prediction of dose distribution. However, besides the computed tomography (CT) image, these methods usually require extra segmentation masks such as tumor target and organs at risk (OARs) as prior knowledge, and acquiring such annotations are quite time-consuming. In this paper, we propose a Dual-path Segmentation-guided Attention Network (DSANet) to directly predict the dose distribution map solely from the CT images. Specifically, considering the high correlation between the tumor anatomical structure and the dose distribution, we develop a dual-path architecture which consists of 1) a primary dose prediction path aiming at generating accurate dose distribution maps, and 2) an auxiliary segmentation path applied to provide attention maps with anatomical information for the primary dose prediction task. Moreover, we design an attention map-guided feature decoupling (AMFD) module to enforce the primary network to focus not only on the high-dose distribution in the tumor area but also on the low-dose distribution in the surrounding regions. Experiments on two in-house datasets demonstrate the effectiveness and generalization of our method.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.